Inventory

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves, as of September 30, 2021 and December 31, 2020 are as follows (table in thousands):

	September 30, 2021		December 31, 2020
Raw Materials	$	3,507	$	3,112
Work in Process	266		172
Finished Goods	1,781		1,805
Total	$	5,554	$	5,089

As of September 30, 2021, the Company classified $1.5 million of inventory as non-current, all of which was related to Triferic or the active pharmaceutical ingredient and raw materials for Triferic. As of September 30, 2021, the total Triferic inventory net of reserve was $1.6 million.

The $1.6 million net value of Triferic inventory consisted of $0.4 million of Triferic (dialysate) finished goods with expiration dates ranging from September 2021 to December 2023, $0.4 million of Triferic API with estimated remaining shelf life extending beyond 2022, and $0.9 million of raw materials for Triferic with estimated remaining shelf life extending beyond 2025.